Hartman Institute for Therapeutic Organ Regeneration

Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.

TitlePlacental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.
Publication TypeJournal Article
Year of Publication2002
AuthorsHattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P, Witte L, Hendrikx J, Hackett NR, Crystal RG, Moore MAS, Werb Z, Lyden D, Rafii S
JournalNat Med
Volume8
Issue8
Pagination841-9
Date Published2002 Aug
ISSN1078-8956
KeywordsAnimals, Antimetabolites, Antineoplastic, Cell Separation, Cell Transplantation, Chemotaxis, Female, Fluorouracil, Hematopoiesis, Hematopoietic Stem Cells, Humans, Male, Matrix Metalloproteinase 9, Mice, Mice, Inbred Strains, Placenta Growth Factor, Pregnancy Proteins, Proto-Oncogene Proteins, Receptor Protein-Tyrosine Kinases, Receptors, Growth Factor, Receptors, Vascular Endothelial Growth Factor, Transplantation Chimera, Transplantation, Heterologous, Vascular Endothelial Growth Factor Receptor-1
Abstract

The mechanism by which angiogenic factors recruit bone marrow (BM)-derived quiescent endothelial and hematopoietic stem cells (HSCs) is not known. Here, we report that functional vascular endothelial growth factor receptor-1 (VEGFR1) is expressed on human CD34(+) and mouse Lin(-)Sca-1(+)c-Kit(+) BM-repopulating stem cells, conveying signals for recruitment of HSCs and reconstitution of hematopoiesis. Inhibition of VEGFR1, but not VEGFR2, blocked HSC cell cycling, differentiation and hematopoietic recovery after BM suppression, resulting in the demise of the treated mice. Placental growth factor (PlGF), which signals through VEGFR1, restored early and late phases of hematopoiesis following BM suppression. PlGF enhanced early phases of BM recovery directly through rapid chemotaxis of VEGFR1(+) BM-repopulating and progenitor cells. The late phase of hematopoietic recovery was driven by PlGF-induced upregulation of matrix metalloproteinase-9, mediating the release of soluble Kit ligand. Thus, PlGF promotes recruitment of VEGFR1(+) HSCs from a quiescent to a proliferative BM microenvironment, favoring differentiation, mobilization and reconstitution of hematopoiesis.

DOI10.1038/nm740
Alternate JournalNat Med
PubMed ID12091880
PubMed Central IDPMC2779715
Grant ListR01 NS039278 / NS / NINDS NIH HHS / United States
R01 HL-66592 / HL / NHLBI NIH HHS / United States
P01 CA072006-07 / CA / NCI NIH HHS / United States
P01 HL067839 / HL / NHLBI NIH HHS / United States
R01 HL-58707 / HL / NHLBI NIH HHS / United States
CA 72006 / CA / NCI NIH HHS / United States
AR46238 / AR / NIAMS NIH HHS / United States
R01 HL61401 / HL / NHLBI NIH HHS / United States
R01 HL061849 / HL / NHLBI NIH HHS / United States
R01 AR046238-03 / AR / NIAMS NIH HHS / United States
CA 75072 / CA / NCI NIH HHS / United States
R01 CA075072-03 / CA / NCI NIH HHS / United States
R01 HL-67839 / HL / NHLBI NIH HHS / United States
R01 AR046238 / AR / NIAMS NIH HHS / United States
P01 CA072006 / CA / NCI NIH HHS / United States
R01 HL61849 / HL / NHLBI NIH HHS / United States
R01 NS039278-05A1 / NS / NINDS NIH HHS / United States
NS39278 / NS / NINDS NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065